Bio-Path Holdings, Inc.

NasdaqCM:BPTH Stock Report

Market Cap: US$4.4m

Bio-Path Holdings Management

Management criteria checks 4/4

Bio-Path Holdings' CEO is Peter Nielsen, appointed in Jan 2007, has a tenure of 17.33 years. total yearly compensation is $827.12K, comprised of 69.5% salary and 30.5% bonuses, including company stock and options. directly owns 0.083% of the company’s shares, worth $3.66K. The average tenure of the management team and the board of directors is 17.3 years and 8 years respectively.

Key information

Peter Nielsen

Chief executive officer

US$827.1k

Total compensation

CEO salary percentage69.5%
CEO tenure17.3yrs
CEO ownership0.08%
Management average tenure17.3yrs
Board average tenure8yrs

Recent management updates

Recent updates

We're Keeping An Eye On Bio-Path Holdings' (NASDAQ:BPTH) Cash Burn Rate

Nov 05
We're Keeping An Eye On Bio-Path Holdings' (NASDAQ:BPTH) Cash Burn Rate

Bio-Path GAAP EPS of -$0.42 beats by $0.07

Aug 16

Is Bio-Path Holdings (NASDAQ:BPTH) In A Good Position To Deliver On Growth Plans?

Jul 08
Is Bio-Path Holdings (NASDAQ:BPTH) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About Bio-Path Holdings' (NASDAQ:BPTH) Cash Burn Situation

Mar 24
Here's Why We're Not Too Worried About Bio-Path Holdings' (NASDAQ:BPTH) Cash Burn Situation

Bio-Path Holdings (NASDAQ:BPTH) Is In A Good Position To Deliver On Growth Plans

Aug 17
Bio-Path Holdings (NASDAQ:BPTH) Is In A Good Position To Deliver On Growth Plans

We Think Bio-Path Holdings (NASDAQ:BPTH) Needs To Drive Business Growth Carefully

Mar 26
We Think Bio-Path Holdings (NASDAQ:BPTH) Needs To Drive Business Growth Carefully

Will Bio-Path Holdings (NASDAQ:BPTH) Spend Its Cash Wisely?

Dec 11
Will Bio-Path Holdings (NASDAQ:BPTH) Spend Its Cash Wisely?

Dosing underway in Bio-Path's early-stage BP1002 study

Nov 19

Bio-Path EPS beats by $0.07

Nov 13

CEO Compensation Analysis

How has Peter Nielsen's remuneration changed compared to Bio-Path Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$827kUS$575k

-US$16m

Sep 30 2023n/an/a

-US$17m

Jun 30 2023n/an/a

-US$17m

Mar 31 2023n/an/a

-US$16m

Dec 31 2022US$1mUS$555k

-US$14m

Sep 30 2022n/an/a

-US$14m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

-US$11m

Dec 31 2021US$1mUS$530k

-US$10m

Sep 30 2021n/an/a

-US$9m

Jun 30 2021n/an/a

-US$10m

Mar 31 2021n/an/a

-US$10m

Dec 31 2020US$1mUS$510k

-US$11m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$10m

Dec 31 2019US$735kUS$490k

-US$9m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$9m

Mar 31 2019n/an/a

-US$8m

Dec 31 2018US$672kUS$490k

-US$9m

Sep 30 2018n/an/a

-US$9m

Jun 30 2018n/an/a

-US$8m

Mar 31 2018n/an/a

-US$10m

Dec 31 2017US$594kUS$475k

-US$8m

Compensation vs Market: Peter's total compensation ($USD827.12K) is about average for companies of similar size in the US market ($USD667.63K).

Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.

CEO

Peter Nielsen (74 yo)

17.3yrs

Tenure

US$827,117

Compensation

Mr. Peter H. Nielsen, MBA, is a Co-Founded Bio-path Holdings, Inc. in 2007 and has been its Chairman, President, Chief Executive Officer, Chief Financial Officer and Treasurer since 2008. Mr. Nielsen licen...

Leadership Team

NamePositionTenureCompensationOwnership
Peter Nielsen
Co-Founder17.3yrsUS$827.12k0.083%
$ 3.7k
Douglas Morris
Co-Founder17.3yrsUS$89.98k0%
$ 0
Michael Hickey
VP of Clinical Operations1.3yrsno datano data
Anthony Price
Senior Vice President of Financeno datano datano data
Ana Ashizawa
Senior Vice President of Researchno datano datano data

17.3yrs

Average Tenure

Experienced Management: BPTH's management team is seasoned and experienced (17.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter Nielsen
Co-Founder16.3yrsUS$827.12k0.083%
$ 3.7k
Douglas Morris
Co-Founder17.3yrsUS$89.98k0%
$ 0
Jorge Cortes
Chairman of the Scientific Advisory Board8.8yrsno datano data
Paul Aubert
Independent Director6.3yrsUS$73.81k0%
$ 0
Jason Fleming
Member of the Scientific Advisory Board5.8yrsno datano data
Heath Cleaver
Independent Director10.3yrsUS$85.31k0%
$ 0
D. Hooper
Member of the Scientific Advisory Board7.3yrsno datano data
Aline Sherwood
Independent Director2.2yrsUS$76.81k0%
$ 0

8.0yrs

Average Tenure

53yo

Average Age

Experienced Board: BPTH's board of directors are considered experienced (8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.